TY - JOUR AU - Satyanarayana, S. AU - Kilari, E. K. PY - 2006 DA - 2006// TI - Influence of nicorandil on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits JO - Mol Cell Biochem VL - 291 UR - https://doi.org/10.1007/s11010-006-9202-y DO - 10.1007/s11010-006-9202-y ID - Satyanarayana2006 ER - TY - JOUR AU - Saely, C. H. AU - Aczel, S. AU - Marte, T. AU - Langer, P. AU - Drexel, H. PY - 2004 DA - 2004// TI - Cardiovascular complications in type 2 diabetes mellitus depends on the coronary angiographic state rather than on the diabetes state JO - Diabetologia VL - 47 UR - https://doi.org/10.1007/s00125-003-1274-6 DO - 10.1007/s00125-003-1274-6 ID - Saely2004 ER - TY - JOUR AU - King, H. AU - Aubert, R. E. AU - Herman, W. H. PY - 1998 DA - 1998// TI - Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections JO - Diabetes Care VL - 21 UR - https://doi.org/10.2337/diacare.21.9.1414 DO - 10.2337/diacare.21.9.1414 ID - King1998 ER - TY - JOUR AU - Harris, M. I. AU - Flegal, K. M. AU - Cowie, C. C. AU - Eberhardt, M. S. AU - Goldstein, D. E. AU - Little, R. R. AU - Wiedmeyer, H. M. AU - Byrd-Holt, D. D. PY - 1998 DA - 1998// TI - Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994 JO - Diabetes Care VL - 21 UR - https://doi.org/10.2337/diacare.21.4.518 DO - 10.2337/diacare.21.4.518 ID - Harris1998 ER - TY - JOUR AU - Hruz, P. W. PY - 2006 DA - 2006// TI - Molecular mechanisms for altered glucose homeostasis in HIV infection JO - Am J Infect Dis VL - 2 UR - https://doi.org/10.3844/ajidsp.2006.187.192 DO - 10.3844/ajidsp.2006.187.192 ID - Hruz2006 ER - TY - JOUR AU - Zimmet, P. AU - Alberti, K. G. M. M. AU - Shaw, J. PY - 2001 DA - 2001// TI - Global and Societal implications of the diabetes epidemic JO - Nature VL - 414 UR - https://doi.org/10.1038/414782a DO - 10.1038/414782a ID - Zimmet2001 ER - TY - JOUR AU - Dube, M. P. PY - 2000 DA - 2000// TI - Disorders of glucose metabolism in patients infected with human immunodeficiency virus JO - Clin Infect Dis VL - 31 UR - https://doi.org/10.1086/317491 DO - 10.1086/317491 ID - Dube2000 ER - TY - JOUR AU - Martinez, E. AU - Arnaiz, J. A. AU - Podzamczer, D. AU - Dalmau, D. AU - Ribera, E. AU - Domingo, P. AU - Knobel, H. AU - Riera, M. AU - Pedrol, E. AU - Force, L. AU - Llibre, J. M. AU - Segura, F. AU - Richart, C. AU - Cortés, C. AU - Javaloyas, M. AU - Aranda, M. AU - Cruceta, A. AU - Lazzari, E. D. AU - Gatell, J. M. PY - 2003 DA - 2003// TI - Substitution of Nevirapine, Efavirenz, or Abacavir for protease inhibitors in patients with human immunodeficiency virus infection JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa021589 DO - 10.1056/NEJMoa021589 ID - Martinez2003 ER - TY - JOUR AU - Saag, M. S. AU - Powderly, W. G. AU - Schambelan, M. AU - Benson, C. A. AU - Carr, A. AU - Currier, J. S. AU - Dubé, M. P. AU - Gerber, J. G. AU - Grinspoon, S. K. AU - Grunfeld, C. AU - Kotler, D. P. AU - Mulligan, K. PY - 2002 DA - 2002// TI - Switching antiretroviral drugs for treatment of metabolic complications in HIV-1 infection: summary of selected trials JO - Topics in HIV Med VL - 10 ID - Saag2002 ER - TY - JOUR AU - Martínez, E. AU - García-Viejo, M. A. AU - Blanco, J. L. AU - Bianchi, L. AU - Buira, E. AU - Conget, I. AU - Casamitjana, R. AU - Mallolas, J. AU - Gatell, J. M. PY - 2000 DA - 2000// TI - Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy JO - Clin Infect Dis VL - 31 UR - https://doi.org/10.1086/317426 DO - 10.1086/317426 ID - Martínez2000 ER - TY - JOUR AU - Martínez, E. AU - Conget, I. AU - Lozano, L. AU - Casamitjana, R. AU - Gatell, J. M. PY - 1999 DA - 1999// TI - Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine JO - AIDS VL - 13 UR - https://doi.org/10.1097/00002030-199905070-00009 DO - 10.1097/00002030-199905070-00009 ID - Martínez1999 ER - TY - JOUR AU - Walli, R. K. AU - Michl, G. M. AU - Bogner, J. R. AU - Goebel, F. D. PY - 2001 DA - 2001// TI - Improvement of HAART-associated insulin resistance and dyslipidemia after replacement of protease inhibitors with abacavir JO - Eur J Med Res VL - 6 ID - Walli2001 ER - TY - JOUR AU - Schernthaner, G. PY - 2003 DA - 2003// TI - Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects JO - Metabolism VL - 52 UR - https://doi.org/10.1016/S0026-0495(03)00215-4 DO - 10.1016/S0026-0495(03)00215-4 ID - Schernthaner2003 ER - TY - JOUR AU - Song, D. K. AU - Ashcroft, F. M. PY - 2001 DA - 2001// TI - Glimepiride block of cloned β cell, cardiac and smooth muscle KATP channels JO - Br J Pharmacol VL - 133 UR - https://doi.org/10.1038/sj.bjp.0704062 DO - 10.1038/sj.bjp.0704062 ID - Song2001 ER - TY - JOUR AU - Gribble, F. M. AU - Tucker, S. J. AU - Seino, S. AU - Ashcroft, F. M. PY - 1998 DA - 1998// TI - Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K (ATP) channels JO - Diabetes VL - 47 UR - https://doi.org/10.2337/diabetes.47.9.1412 DO - 10.2337/diabetes.47.9.1412 ID - Gribble1998 ER - TY - JOUR AU - Jennings, P. E. AU - Belch, J. J. F. PY - 2001 DA - 2001// TI - Free radical scavenging activity of sulphonylureas: a clinical assessment of the effectiveness of gliclazide JO - Ter Arkh VL - 73 ID - Jennings2001 ER - TY - JOUR AU - Brien, R. C. AU - Luo, M. AU - Balazs, N. AU - Mercuri, J. PY - 2000 DA - 2000// TI - In vitro and in vivo antioxidant properties of gliclazide JO - J Diabet Complications VL - 14 UR - https://doi.org/10.1016/S1056-8727(00)00084-2 DO - 10.1016/S1056-8727(00)00084-2 ID - Brien2000 ER - TY - JOUR AU - Homes, B. AU - Heel, R. C. AU - Brogden, R. N. AU - Speight, T. M. AU - Avery, G. S. PY - 1984 DA - 1984// TI - Gliclazide-a preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus JO - Drugs VL - 27 UR - https://doi.org/10.2165/00003495-198427040-00002 DO - 10.2165/00003495-198427040-00002 ID - Homes1984 ER - TY - JOUR AU - Harrower, A. D. B. PY - 2000 DA - 2000// TI - Comparative tolerability of sulphonylureas in diabetes mellitus JO - Drug Safety VL - 22 UR - https://doi.org/10.2165/00002018-200022040-00004 DO - 10.2165/00002018-200022040-00004 ID - Harrower2000 ER - TY - JOUR AU - Harrower, A. D. B. PY - 1991 DA - 1991// TI - Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM JO - Diabetes Res Clin Pract VL - 14 UR - https://doi.org/10.1016/0168-8227(91)90010-B DO - 10.1016/0168-8227(91)90010-B ID - Harrower1991 ER - TY - JOUR AU - Ziegler, O. AU - Drouin, P. PY - 1994 DA - 1994// TI - Hemobiological properties of gliclazide JO - J Diabet Complications VL - 8 UR - https://doi.org/10.1016/1056-8727(94)90050-7 DO - 10.1016/1056-8727(94)90050-7 ID - Ziegler1994 ER - TY - JOUR AU - Palmer, K. J. AU - Brogden, R. N. PY - 1993 DA - 1993// TI - Gliclazide: an update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus JO - Drugs VL - 46 UR - https://doi.org/10.2165/00003495-199346010-00007 DO - 10.2165/00003495-199346010-00007 ID - Palmer1993 ER - TY - JOUR AU - Fava, D. AU - Cassone-Faldetta, M. AU - Laurenti, O. AU - De luca, O. AU - Ghiselli, A. AU - De Mattia, G. PY - 2002 DA - 2002// TI - Gliclazide improves antioxidant status and nitric oxide mediated vasodilation in type-2 diabetes JO - Diabetes Med VL - 19 UR - https://doi.org/10.1046/j.1464-5491.2002.00762.x DO - 10.1046/j.1464-5491.2002.00762.x ID - Fava2002 ER - TY - CHAP AU - Paget, G. E. AU - Barnes, J. M. ED - Laurence, D. R. ED - Bacharach, A. L. PY - 1964 DA - 1964// TI - From toxicity tests BT - evaluation of drug activities: pharmacometrics PB - Academic Press CY - London ID - Paget1964 ER - TY - JOUR AU - Berruet, N. AU - Sentenac, S. AU - Auchere, D. AU - Gimenez, F. AU - Farinotti, R. AU - Fernandez, C. PY - 2005 DA - 2005// TI - Effect of efavirenz on intestinal p-glycoprotein and hepatic p450 function in rats JO - J Pharm Pharm Sci VL - 8 ID - Berruet2005 ER - TY - JOUR AU - Kishimoto, W. AU - Takano, J. AU - Senda, C. AU - Ishiguro, N. AU - Sakai, K. AU - Garashi, T. PY - 2000 DA - 2000// TI - Quantitative prediction of in vivo drug interactions between nevirapine and antifungal agents from in vitro data in rats JO - Biol Pharm Bull VL - 23 UR - https://doi.org/10.1248/bpb.23.1027 DO - 10.1248/bpb.23.1027 ID - Kishimoto2000 ER - TY - JOUR AU - Heikkila, R. E. PY - 1977 DA - 1977// TI - The prevention of alloxan-induced diabetes in mice by dimethyl sulfoxide JO - Eur J Pharmacol VL - 44 UR - https://doi.org/10.1016/0014-2999(77)90106-6 DO - 10.1016/0014-2999(77)90106-6 ID - Heikkila1977 ER - TY - JOUR AU - Riley, V. PY - 1960 DA - 1960// TI - Adaptation of orbital bleeding technique to rapid serial blood studies JO - Proc Soc Exp Biol Med VL - 104 UR - https://doi.org/10.3181/00379727-104-25975 DO - 10.3181/00379727-104-25975 ID - Riley1960 ER - TY - JOUR AU - Trinder, P. PY - 1969 DA - 1969// TI - Determination of blood glucose using an oxidaase-peroxidase system with a non carcinogenic chemogen JO - J Clin Pathol VL - 22 UR - https://doi.org/10.1136/jcp.22.2.158 DO - 10.1136/jcp.22.2.158 ID - Trinder1969 ER - TY - JOUR AU - Miyazaki, H. AU - Fijii, T. AU - Yoshida, K. AU - Arakawa, S. AU - Furukawa, H. PY - 1983 DA - 1983// TI - Disposition and metabolism of [3H] gliclazide in rats JO - Eur J Drug Metab Pharmacokinet VL - 8 UR - https://doi.org/10.1007/BF03188737 DO - 10.1007/BF03188737 ID - Miyazaki1983 ER - TY - JOUR AU - Viggneri, R. AU - Pezzino, V. AU - Wong, K. Y. AU - Goldfine, I. D. PY - 1982 DA - 1982// TI - Comparison of the in vitro effect of biguanides and sulfonylureas on the insulin binding to its receptors in target cells JO - J Clin Endocrinol Metab VL - 54 UR - https://doi.org/10.1210/jcem-54-1-95 DO - 10.1210/jcem-54-1-95 ID - Viggneri1982 ER - TY - JOUR AU - Campbell, D. B. AU - Lavielle, R. AU - Nathan, C. PY - 1991 DA - 1991// TI - The mode of action and clinical pharmacology of gliclazide a review JO - Diabetes Res Clin Pract VL - 14 UR - https://doi.org/10.1016/0168-8227(91)90005-X DO - 10.1016/0168-8227(91)90005-X ID - Campbell1991 ER - TY - JOUR AU - Chiasson, J. L. AU - Hamet, P. AU - Vercly, M. PY - 1991 DA - 1991// TI - The effect of Diamicron® on the secretion and action of insulin JO - Diabetes Res Clin Pract VL - 14 UR - https://doi.org/10.1016/0168-8227(91)90007-Z DO - 10.1016/0168-8227(91)90007-Z ID - Chiasson1991 ER - TY - JOUR AU - Ma, A. AU - Kamp, M. AU - Bird, D. PY - 1989 DA - 1989// TI - The effects of long term gliclazide administration on insulin secretion and insulin sensitivity JO - Aus N Z J Med VL - 19 UR - https://doi.org/10.1111/j.1445-5994.1989.tb01674.x DO - 10.1111/j.1445-5994.1989.tb01674.x ID - Ma1989 ER - TY - JOUR AU - Vanhaeften, T. W. AU - Vaneman, T. F. AU - Gerich, J. E. PY - 1991 DA - 1991// TI - Influence of gliclazide on glucose stimulated insulin release in man JO - Metabolism VL - 40 UR - https://doi.org/10.1016/0026-0495(91)90096-F DO - 10.1016/0026-0495(91)90096-F ID - Vanhaeften1991 ER - TY - JOUR AU - Wajchenberg, B. L. AU - Santomauro, A. T. M. G. AU - Porrelli, R. N. PY - 1993 DA - 1993// TI - Effect of sulfonylurea (gliclazide) treatment on insulin sensitivity and glucose mediated, glucose disposal in patients with non-insulin dependent diabetes mellitus (NIDDM) JO - Diabetes Res Clin Pract VL - 20 UR - https://doi.org/10.1016/0168-8227(93)90009-T DO - 10.1016/0168-8227(93)90009-T ID - Wajchenberg1993 ER - TY - JOUR AU - Adkins, J. C. AU - Noble, S. PY - 1998 DA - 1998// TI - Efavirenz JO - Drugs VL - 56 UR - https://doi.org/10.2165/00003495-199856060-00014 DO - 10.2165/00003495-199856060-00014 ID - Adkins1998 ER - TY - JOUR AU - Von Moltke, L. L. AU - Greenblatt, D. J. AU - Granda, B. W. AU - Giancarlo, G. M. AU - Duan, S. X. AU - Daily, J. P. AU - Harmatz, J. S. AU - Shader, R. I. PY - 2001 DA - 2001// TI - Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors JO - J Clin Pharmacol VL - 41 UR - https://doi.org/10.1177/00912700122009728 DO - 10.1177/00912700122009728 ID - Von Moltke2001 ER - TY - JOUR AU - Mouly, S. AU - Lown, K. S. AU - Kornhausir, D. AU - Joseph, J. L. AU - Fiske, W. D. AU - Benedek, I. A. AU - Watkins, P. B. PY - 2002 DA - 2002// TI - Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans JO - Clin Pharmacol Ther VL - 72 UR - https://doi.org/10.1067/mcp.2002.124519 DO - 10.1067/mcp.2002.124519 ID - Mouly2002 ER - TY - JOUR AU - Hariprasad, N. AU - Nallani, S. C. AU - Sane, R. S. AU - Buckley, D. J. AU - Buckley, A. R. AU - Desai, P. B. PY - 2004 DA - 2004// TI - Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital JO - J Clin Pharmacol VL - 44 UR - https://doi.org/10.1177/0091270004269142 DO - 10.1177/0091270004269142 ID - Hariprasad2004 ER - TY - JOUR AU - Falloon, J. AU - Piscitelli, S. AU - Vogel, S. AU - Sadler, D. AU - Mitsuya, H. AU - Karlick, M. F. AU - Yushimura, K. AU - Rogers, M. AU - LaFon, S. AU - Manion, D. J. AU - Lane, H. C. AU - Masur, H. PY - 2000 DA - 2000// TI - Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity JO - Clin Infect Dis VL - 30 UR - https://doi.org/10.1086/313667 DO - 10.1086/313667 ID - Falloon2000 ER - TY - JOUR AU - Clarke, S. M. AU - Mulcahy, F. M. AU - Tjia, J. AU - Reynolds, H. E. AU - Gibbons, S. E. AU - Barry, M. G. AU - Back, D. J. PY - 2001 DA - 2001// TI - The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz JO - Br J Clin Pharmacol VL - 51 UR - https://doi.org/10.1046/j.1365-2125.2001.00342.x DO - 10.1046/j.1365-2125.2001.00342.x ID - Clarke2001 ER - TY - JOUR AU - Arnoutse, R. E. AU - Grintjes, K. J. T. AU - Telgt, D. S. C. AU - Stel, M. AU - Hugen, P. W. H. AU - Reiss, P. AU - Koopmans, P. P. AU - Hekster, Y. A. AU - Burger, D. M. PY - 2002 DA - 2002// TI - The interaction of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers JO - Clin Pharmacol Ther VL - 71 UR - https://doi.org/10.1067/mcp.2002.121424 DO - 10.1067/mcp.2002.121424 ID - Arnoutse2002 ER - TY - JOUR AU - Liu, P. AU - Foster, G. AU - LaBadie, R. R. AU - Gutierrez, M. J. AU - Sharma, A. PY - 2008 DA - 2008// TI - Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects JO - J Clin Pharmacol VL - 48 UR - https://doi.org/10.1177/0091270007309703 DO - 10.1177/0091270007309703 ID - Liu2008 ER - TY - JOUR AU - Campbell, D. B. AU - Lavielle, R. AU - Nathan, C. PY - 1991 DA - 1991// TI - The mode of action on clinical pharmacology of gliclazide a review JO - Diabetes Res Clin Pract VL - 14 UR - https://doi.org/10.1016/0168-8227(91)90005-X DO - 10.1016/0168-8227(91)90005-X ID - Campbell1991 ER - TY - STD TI - SUSTIVA® U.S. FDA approval: 1998, Accessed September 15, 2009, [http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021360s018,020972s031lbl.pdf] UR - http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021360s018,020972s031lbl.pdf ID - ref46 ER - TY - JOUR AU - Marzolini, C. AU - Troillet, N. AU - Telenti, A. AU - Baumann, P. AU - Decosterd, L. A. AU - Eap, C. B. PY - 2000 DA - 2000// TI - Efavirenz decreases methadone blood concentrations JO - AIDS VL - 14 UR - https://doi.org/10.1097/00002030-200006160-00036 DO - 10.1097/00002030-200006160-00036 ID - Marzolini2000 ER - TY - STD TI - VIRAMUNE® U.S. FDA approval: 1996, Accessed September 15, 2009, [http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020636s027,020933s017lbl.pdf] UR - http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020636s027,020933s017lbl.pdf ID - ref48 ER - TY - JOUR AU - Lamson, M. J. AU - Cort, S. AU - Sabo, J. P. AU - MacGregor, T. R. AU - Keirns, J. J. PY - 1995 DA - 1995// TI - Effects of gender on the single and multiple dose pharmacokinetics of nevirapine JO - Pharmacol Res VL - 12 ID - Lamson1995 ER - TY - JOUR AU - Riska, P. AU - Lamson, M. AU - Macgregor, T. AU - Sabo, J. AU - Hattox, S. AU - Pav, J. AU - Keirns, J. PY - 1999 DA - 1999// TI - Disposition and biotransformation of the antiretroviral drug nevirapine in humans JO - Drug Metab Dispos VL - 27 ID - Riska1999 ER -